John Winkelman, MD, PhD, Chief of the Sleep Disorders Clinical Research Program in Psychiatry, has received the 2020 Ekbom Award from the Restless Legs Syndrome (RLS) Foundation. This prestigious award honors individuals who have enhanced the lives of people with RLS and made significant contributions to the RLS community. Dr. Winkelman was among the researchers who conducted studies that led to the approval by the FDA, in 2005, of the first dopamine agonist for treatment of RLS. His treatment and care of his thousands of RLS patients over the years is what makes him so beloved by this community.
John Winkelman, MD PhD is theChief of theSleep Disorders Clinical Research Programin the Department of Psychiatry at Mass General and Professor of Psychiatry at Harvard Medical School. Dr. Winkelman's research has primarily focused in two areas: 1) epidemiology, physiology, cardiovascular consequences and treatment of restless legs syndrome, and 2) neurobiology and treatment of insomnia.
